Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid rafts are specialized, highly ordered microdomains within the plasma membrane lipid bilayer, enriched in cholesterol, sphingolipids, and specific proteins like caveolins and flotillins (Mollinedo & Gajate, 2015). In cancer cells, these microdomains are often more abundant or altered in composition, serving as critical platforms for the assembly and activation of pro-survival and pro-migratory signaling pathways, including the PI3K/Akt and MAPK pathways (Patra, 2008). Targeting these structures, a strategy known as membrane lipid therapy, aims to disrupt the spatial organization of oncogenic receptors and signaling molecules (Li et al., 2022). Drugs such as synthetic alkylphospholipids, including edelfosine and miltefosine, selectively accumulate in cancer cell rafts, inducing apoptosis by displacing survival signals or recruiting death receptors like Fas/CD95 (Gajate & Mollinedo, 2014). While promising for overcoming multidrug resistance, the therapeutic challenge lies in achieving high selectivity for malignant rafts over those in healthy cells to minimize systemic toxicity (Greenlee et al., 2021).
Disruption of membrane microdomain structural integrity, depletion of membrane cholesterol, and displacement of oncogenic signaling proteins from the plasma membrane to induce apoptosis.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cancer cell plasma membrane lipid raft microdomain (LR).